MODEL-AD's Avatar

MODEL-AD

@model-ad

Model Organism Development and Evaluation for Late-onset AD. NIA collaborative effort between IU, JAX, UPitt, UCI & Sage Bionetworks to develop new models for LOAD for unrestricted use. www.model-ad.org

264
Followers
3
Following
2
Posts
06.12.2023
Joined
Posts Following

Latest posts by MODEL-AD @model-ad

MODEL-AD Probably Has Something for You | ALZFORUM

We probably have something for you! www.alzforum.org/news/confere...

18.11.2024 14:54 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Mouse Model LOADs on the Alzheimer’s Risk Factors | ALZFORUM

AlzForum reports on our latest MODEL-AD efforts to study late-onset Alzheimer's disease in mice starting from genetic and environmental risk factors rather than familial transgenes: #EndALZ @model-ad.bsky.social

19.01.2024 16:46 πŸ‘ 0 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Preview
In vivo validation of late-onset Alzheimer's disease genetic risk factors https://www.biorxiv.org/content/10.1101/2023.12.21.572849v1 Introduction: Genome-wide association studies have identified over 70 genetic loci associated with l

In vivo validation of late-onset Alzheimer's disease genetic risk factors https://www.biorxiv.org/content/10.1101/2023.12.21.572849v1

24.12.2023 06:16 πŸ‘ 2 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Preview
Metabolomics profiling reveals distinct, sex-specific signatures in the serum and brain metabolomes in the mouse models of Alzheimer's disease https://www.biorxiv.org/content/10.1101/2023.12.22.573059v1 INTRODUCTION: Increasing evidence suggests that metabolic impairments contribute to early Alzheimer'

Metabolomics profiling reveals distinct, sex-specific signatures in the serum and brain metabolomes in the mouse models of Alzheimer's disease https://www.biorxiv.org/content/10.1101/2023.12.22.573059v1

22.12.2023 22:15 πŸ‘ 2 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Preview
Characterizing Molecular and Synaptic Signatures in Mouse Models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau Pathology https://www.biorxiv.org/content/10.1101/2023.12.19.571985v1 INTRODUCTION: MODEL-AD is creating and distributing novel mouse models with humanized, clinically re

Characterizing Molecular and Synaptic Signatures in Mouse Models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau Pathology https://www.biorxiv.org/content/10.1101/2023.12.19.571985v1

20.12.2023 12:16 πŸ‘ 2 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

MARMO-AD has arrived on BlueSky! Follow us for research updates and news from the MARMO-AD team.

13.12.2023 16:09 πŸ‘ 5 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0

MODEL-AD has arrived!

Follow us for updates on new mouse models for Alzheimer's research, open data resources from animal models, and where to find us at your favorite conferences. #EndAlz

06.12.2023 16:13 πŸ‘ 8 πŸ” 3 πŸ’¬ 1 πŸ“Œ 0